In a recent study, talk therapy in Parkinson’s disease led to significant improvement in patients' well-being, ...
Researchers at Karolinska Institutet have discovered new insights into brain changes in Parkinson's disease using advanced ...
From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...
The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...
The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity.
Danish film director Lars von Trier has been admitted to a care facility for Parkinson’s disease, his producer said Wednesday ...
Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...
Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...
The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...
Dec. 18, 2024 — Dancing lowers the depression associated with Parkinson's disease, and the benefits can be seen in multiple ways, a new study ... Nov. 19, 2024 — A recently published study ...
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...
The Associated Press on MSN8d
Conductor Daniel Barenboim says he’s been diagnosed with Parkinson’s diseaseConductor Daniel Barenboim says he has been diagnosed with Parkinson’s disease. The 82-year-old issued a statement Thursday ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results